Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
14.62
+1.31 (9.84%)
At close: Oct 9, 2026, 4:00 PM EDT
14.60
-0.02 (-0.14%)
After-hours: Oct 9, 2026, 7:57 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $6.62 billion as of October 9, 2026. It is the 2,977th most valuable company in the world and the 968th biggest in the United States. Its market cap has increased by 706.24% in one year.
Market Cap
6.62B
Enterprise Value
6.37B
1-Year Change
706.24%
Global Rank
Country Rank
#968 United States
Category
ChartMarket Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $6.62B, an increase of 2,607.46%. That is a compound annual growth rate of 32.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 6.62B | 511.09% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.71B |
| Ionis Pharmaceuticals | 7.52B |
| Praxis Precision Medicines | 7.26B |
| Immunovant | 6.29B |
| Kodiak Sciences | 6.26B |
| Rhythm Pharmaceuticals | 6.25B |
| Belite Bio | 6.22B |
| Ligand Pharmaceuticals | 6.02B |